Badrul Chowdhury. FDA via Flickr
AstraZeneca loses another executive to biotech, as Badrul Chowdhury moves to Savara
Another executive is migrating from the echelons of Big Pharma to the corridors of small biotech.
In April 2018, Badrul Chowdhury took his more than …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
